drugset

drugset / Trial / NCT04053985

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

NCT04053985 ↗

Phase 3 Unknown 206 enrolled Sun Yat-sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

evaluation of the efficacy of transarterial chemoinfusion (TAI) combine lenvatinib in advanced hepatocelllar carcinoma

Timeline

Start: 2018-01-01
Primary completion: 2022-12-31
Completion: 2022-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lenvatinib	Small molecule	—	—

Indications